Advantages in combination chemotherapy using cisplatin and its analogues for human testicular tumor xenografts.

Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.

Acute cerebrovascular event after cisplatin-based chemotherapy for testicular cancer.

Implications of successful combination chemotherapy for testicular germ cell neoplasms.

Testicular function after combination chemotherapy for Hodgkin's disease.

Stat Bite. Impact of combination chemotherapy for advanced testicular cancer.

Cisplatin combination chemotherapy for elderly patients with urothelial tumours.

Cisplatin neuropathy in brain tumor chemotherapy.

Intermittent intensive combination chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (cyclic PAC chemotherapy) for ovarian cancer.

'Two-route chemotherapy' using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer.

Management of Chemotherapy Induced Nausea and Vomiting in Patients on Multiday Cisplatin Based Combination Chemotherapy.

Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.

Diphtheria toxin effects on brain-tumor xenografts. Implications for protein-based brain-tumor chemotherapy.

Mesoporous Silica Nanoparticles Loaded with Cisplatin and Phthalocyanine for Combination Chemotherapy and Photodynamic Therapy in vitro.

Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.

Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.

Synthesis, cytotoxicity and apoptosis induction in human tumor cells by galaxamide and its analogues [corrected].

Association of metallothionein expression and clinical response to cisplatin based chemotherapy in testicular germ cell tumors.

Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer.

Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer.

Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia.

Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapy.

Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinoma.

Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposide.

Stevens-Johnson Syndrome Patient Received Combination Chemotherapy Gemcitabine, Cisplatin, and 5-FU for Biliary Tract Cancer.

Suggest Documents

Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.

Acute cerebrovascular event after cisplatin-based chemotherapy for testicular cancer.

Implications of successful combination chemotherapy for testicular germ cell neoplasms.

Testicular function after combination chemotherapy for Hodgkin's disease.

Stat Bite. Impact of combination chemotherapy for advanced testicular cancer.

Cisplatin combination chemotherapy for elderly patients with urothelial tumours.

Cisplatin neuropathy in brain tumor chemotherapy.

Intermittent intensive combination chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (cyclic PAC chemotherapy) for ovarian cancer.

'Two-route chemotherapy' using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer.

Management of Chemotherapy Induced Nausea and Vomiting in Patients on Multiday Cisplatin Based Combination Chemotherapy.

Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.

Diphtheria toxin effects on brain-tumor xenografts. Implications for protein-based brain-tumor chemotherapy.

Mesoporous Silica Nanoparticles Loaded with Cisplatin and Phthalocyanine for Combination Chemotherapy and Photodynamic Therapy in vitro.

Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.

Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.

Synthesis, cytotoxicity and apoptosis induction in human tumor cells by galaxamide and its analogues [corrected].

Association of metallothionein expression and clinical response to cisplatin based chemotherapy in testicular germ cell tumors.

Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer.

Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer.

Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia.

Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapy.

Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinoma.

Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposide.

Stevens-Johnson Syndrome Patient Received Combination Chemotherapy Gemcitabine, Cisplatin, and 5-FU for Biliary Tract Cancer.

Advantages in combination chemotherapy using cisplatin and its analogues for human testicular tumor xenografts.

Recommend Documents

Follow Us